Mar. 12, 2026
Kymera Therapeutics Celebrates 10-Year Anniversary
Biotech company highlights disciplined approach to targeting unmet needs
Mar. 11, 2026
Aura Biosciences Advances Novel Therapies, Eyes Key Enrollment Milestone
Company reaffirms timeline for Phase 3 choroidal melanoma data, outlines additional ocular oncology and bladder cancer development plans
Mar. 10, 2026
Regeneron Presents at Barclays Healthcare Conference
Biotech company discusses commercial and investor relations updates.
Mar. 5, 2026
South Florida's 'Miracle Berry' Helps Cancer Patients Taste Food Again During Chemotherapy
The small red Synsepalum dulcificum berry is changing the game for those struggling with taste changes from cancer treatment.
Mar. 4, 2026
Miracle Fruit Helps Cancer Patients Enjoy Food by Changing Taste Buds
Red berries in South Florida make sour and bitter foods taste sweet for cancer patients undergoing chemotherapy
Mar. 4, 2026
MIRA Pharmaceuticals Completes Phase 1 Dosing of Ketamir-2
Advancing a selective oral NMDA receptor modulator toward Phase 2a in chemotherapy-induced peripheral neuropathy following favorable Phase 1 safety and tolerability findings.
Mar. 3, 2026
Dolphins Cancer Challenge Surpasses $100M Raised for Cancer Research
Annual cycling event demonstrates the growing popularity of charity rides as powerful fundraising tools.
Mar. 2, 2026
Immuneering to Present at Leerink Global Healthcare Conference
The late-stage clinical oncology company will discuss its pipeline, platform, and business strategy.
Feb. 28, 2026
Best Buddies CEO Rides with Special Companion in Dolphins Cancer Challenge
Thousands of bicyclists prepare for annual fundraiser in South Florida
